AMED
Signal
Leaning Bullish11!
Price
1
Move+0.01%Quiet session
Volume
1
Volume2.0× avgHeavy volume
Technical
1
RSIRSI 75Overbought
PRICE
Prev Close
100.98
Open
101.00
Day Range100.93 – 101.02
100.93
101.02
52W Range82.15 – 101.02
82.15
101.02
100% of range
VOLUME & SIZE
Avg Volume
517.9K
FUNDAMENTALS
P/E Ratio
39.3x
EPS (TTM)
Div Yield
No dividend
Beta
1.09
Market-like
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +5% YoY · 55% gross margin
Valuation
EXPENSIVE
P/E 39x vs ~20x sector
Health
STRONG
CR 1.4 · FCF $3.96/sh
Bullish
Key MetricsTTM
Market Cap$3.32B
Revenue TTM$2.40B
Net Income TTM$149.69M
Free Cash Flow$234.18M
Gross Margin55.4%
Net Margin6.0%
Operating Margin3.8%
Return on Equity9.1%
Return on Assets4.9%
Debt / Equity0.37
Current Ratio1.36
EPS TTM$3.29

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong4 watch1 concern
42/100
Liquidity
1.36Watch
Leverage
0.37Strong
Coverage
3.5xWatch
ROE
9.1%Watch
ROIC
2.1%Concern
Cash
$303MWatch
ANALYST COVERAGE28 analysts
HOLD
+60.9%upside to target
L $85.00
Med $162.50consensus
H $190.00
Buy
829%
Hold
1864%
Sell
27%
8 Buy (29%)18 Hold (64%)2 Sell (7%)
Full report →
Stock Health
Composite Score
1 of 4 signals bullish
6/10
Technicals
RSI RangeRSI 75 — Overbought, caution
~
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 1.36
~

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentOct 29, 2026
In 179 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

UptrendGolden Cross · 50D leads 200D by 10.3%

+0.0% vs SMA 50 · +10.3% vs SMA 200

Momentum

RSI74.7
Overbought — pullback risk
MACD+0.00
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$101.0+0.0%
Current
$101.0
EMA 50
$100.9-0.1%
EMA 200
$91.59-9.3%
52W Low
$82.15-18.7%
52-Week RangeNear 52-week high
$82.15100th %ile$101.0
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 10 analysts
Analyst revisions:EPS↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$2.3B
$2.2B$2.4B
$2.82
±3%
High5
FY2024
$2.3B
$2.3B$2.4B
+2.6%$4.38+55.5%
±2%
High10
FY2025
$2.5B
$2.4B$2.5B
+4.9%$5.09+16.3%
±4%
High7
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryAMED
Last 8Q
-1.2%avg beat
Beat 4 of 8 quartersMissed 4 Estimates rising
-9%
Q4'23
-9%
Q1'24
+2%
Q2'24
+8%
Q3'24
-15%
Q4'24
-9%
Q1'25
+11%
Q2'25
+11%
Q3'25
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Deutsche BankBuy → Hold
Jul 29
DOWNGRADE
William BlairMarket Perform
Jul 1
DOWNGRADE
Raymond JamesOutperform → Market Perform
Oct 27
DOWNGRADE
BMO CapitalOutperform
Feb 25
UPGRADE
Insider Activity
SEC Filings →
0 Buys/2 SellsNet Selling
Guidroz AllysonChief Accounti…
$36K
May 8
SELL
Guidroz AllysonChief Accounti…
$188K
Mar 4
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
Point72 Asia (Singapore) Pte. Ltd.
0
2
SHELL ASSET MANAGEMENT CO
0
3
BARDIN HILL MANAGEMENT PARTNERS LP
0
4
First Affirmative Financial Network
0
5
Cubist Systematic Strategies, LLC
0
6
Glenmede Investment Management, LP
0
7
Eisler Capital Management Ltd.
0
8
FSA Wealth Management LLC
0
News & Activity

AMED News

20 articles · 4h ago

About

amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i

CEO
Paul Kusserow
Kendra KimmonsVice President of Marketing & Communications & Media Relations
Francis MayerSenior Vice President of Development
Pete HartleyChief Technology Officer & Senior Vice President of Business Operations Systems